Cálculo
Ratio de margen de beneficio neto | = | 100 | × | Utilidad neta1 | ÷ | Ventas netas1 | |
---|---|---|---|---|---|---|---|
31 dic. 2021 | 28.73% | = | 100 | × | 1,503,100) | ÷ | 5,232,500) |
31 dic. 2020 | 18.77% | = | 100 | × | 823,400) | ÷ | 4,386,300) |
31 dic. 2019 | 24.08% | = | 100 | × | 1,046,900) | ÷ | 4,348,000) |
31 dic. 2018 | 19.40% | = | 100 | × | 722,200) | ÷ | 3,722,800) |
31 dic. 2017 | 16.99% | = | 100 | × | 583,600) | ÷ | 3,435,300) |
31 dic. 2016 | 19.22% | = | 100 | × | 569,500) | ÷ | 2,963,700) |
31 dic. 2015 | 19.85% | = | 100 | × | 494,900) | ÷ | 2,493,700) |
31 dic. 2014 | 34.92% | = | 100 | × | 811,100) | ÷ | 2,322,900) |
31 dic. 2013 | 19.15% | = | 100 | × | 391,700) | ÷ | 2,045,500) |
31 dic. 2012 | 15.43% | = | 100 | × | 293,200) | ÷ | 1,899,600) |
31 dic. 2011 | 14.10% | = | 100 | × | 236,700) | ÷ | 1,678,600) |
31 dic. 2010 | 15.07% | = | 100 | × | 218,000) | ÷ | 1,447,000) |
31 dic. 2009 | 17.34% | = | 100 | × | 229,100) | ÷ | 1,321,400) |
31 dic. 2008 | 10.41% | = | 100 | × | 128,900) | ÷ | 1,237,700) |
31 dic. 2007 | 10.36% | = | 100 | × | 113,000) | ÷ | 1,091,100) |
31 dic. 2006 | 12.58% | = | 100 | × | 130,500) | ÷ | 1,037,000) |
31 dic. 2005 | 7.95% | = | 100 | × | 79,300) | ÷ | 997,900) |
Basado en los informes: 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
1 US$ en miles
Comparación con la competencia
Edwards Lifesciences Corp., ratio de margen de beneficio neto, tendencias a largo plazo, comparación con los competidores
Edwards Lifesciences Corp. | Abbott Laboratories | Cigna Group | CVS Health Corp. | Elevance Health Inc. | Humana Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
---|---|---|---|---|---|---|---|---|---|
31 dic. 2021 | 28.73% | 16.42% | 3.11% | 2.72% | 4.46% | 3.54% | 29.85% | 11.97% | 6.06% |
31 dic. 2020 | 18.77% | 12.99% | 5.31% | 2.68% | 3.78% | 4.43% | 24.33% | 16.56% | 6.03% |
31 dic. 2019 | 24.08% | 11.56% | 3.35% | 2.59% | 4.66% | 4.20% | 30.80% | 15.16% | 5.76% |
31 dic. 2018 | 19.40% | 7.74% | 5.59% | -0.31% | 4.11% | 2.98% | 30.29% | 10.36% | 5.33% |
31 dic. 2017 | 16.99% | 1.74% | 5.51% | 3.58% | 4.31% | 4.59% | 21.09% | 13.56% | 5.28% |
31 dic. 2016 | 19.22% | 6.71% | 4.87% | 3.00% | 2.93% | 1.14% | 27.21% | 12.27% | 3.81% |
31 dic. 2015 | 19.85% | 21.68% | 5.71% | 3.42% | 3.27% | 2.37% | 24.69% | 13.20% | 3.72% |
31 dic. 2014 | 34.92% | 11.28% | 6.26% | 3.33% | 3.52% | 2.38% | 19.65% | 18.02% | 4.33% |
31 dic. 2013 | 19.15% | 11.79% | 4.76% | 3.62% | 3.55% | 3.01% | 29.62% | 20.90% | 4.62% |
31 dic. 2012 | 15.43% | 14.95% | 5.81% | 3.15% | 4.37% | 3.15% | 30.14% | 22.35% | 5.03% |
31 dic. 2011 | 14.10% | 12.17% | 6.38% | 3.23% | 4.42% | 3.89% | 28.17% | 19.43% | 5.08% |
31 dic. 2010 | 15.07% | 13.15% | 6.70% | 3.55% | 4.99% | 3.28% | 27.02% | 19.59% | 4.95% |
31 dic. 2009 | 17.34% | 18.68% | 7.46% | 3.74% | 7.80% | 3.39% | 22.11% | 14.86% | 4.42% |
31 dic. 2008 | 10.41% | 16.53% | 1.60% | 3.67% | 4.04% | 2.25% | 23.35% | 16.51% | 3.70% |
31 dic. 2007 | 10.36% | 13.92% | 6.76% | 3.45% | 5.56% | 3.34% | 24.06% | 22.78% | 6.26% |
31 dic. 2006 | 12.58% | 7.64% | 7.63% | 3.12% | 5.52% | 2.31% | 19.33% | 22.55% | 5.89% |
31 dic. 2005 | 7.95% | 15.10% | 10.60% | 3.31% | 5.53% | 2.16% | 41.41% | 17.94% | 7.36% |
Basado en los informes: 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
Comparativa con el sector industrial: Equipos y servicios para el cuidado de la salud
Edwards Lifesciences Corp., ratio de margen de beneficio neto, tendencias a largo plazo, en comparación con el sector industrial: equipos y servicios para el cuidado de la salud
Edwards Lifesciences Corp. | Equipos y servicios para el cuidado de la salud | |
---|---|---|
31 dic. 2021 | 28.73% | 4.96% |
31 dic. 2020 | 18.77% | 5.21% |
31 dic. 2019 | 24.08% | 4.85% |
31 dic. 2018 | 19.40% | 3.84% |
31 dic. 2017 | 16.99% | 4.92% |
31 dic. 2016 | 19.22% | 3.89% |
31 dic. 2015 | 19.85% | 4.73% |
31 dic. 2014 | 34.92% | 4.72% |
31 dic. 2013 | 19.15% | 5.13% |
31 dic. 2012 | 15.43% | 6.00% |
31 dic. 2011 | 14.10% | 5.84% |
31 dic. 2010 | 15.07% | 6.08% |
31 dic. 2009 | 17.34% | 6.68% |
31 dic. 2008 | 10.41% | 5.29% |
31 dic. 2007 | 10.36% | 6.58% |
31 dic. 2006 | 12.58% | 6.06% |
31 dic. 2005 | 7.95% | 7.52% |
Basado en los informes: 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
Comparación con la industria: Atención médica
Edwards Lifesciences Corp., ratio de margen de beneficio neto, tendencias a largo plazo, en comparación con la industria: atención médica
Edwards Lifesciences Corp. | Atención médica | |
---|---|---|
31 dic. 2021 | 28.73% | 11.48% |
31 dic. 2020 | 18.77% | 7.64% |
31 dic. 2019 | 24.08% | 10.09% |
31 dic. 2018 | 19.40% | 9.13% |
31 dic. 2017 | 16.99% | 7.75% |
31 dic. 2016 | 19.22% | 9.91% |
31 dic. 2015 | 19.85% | 10.98% |
31 dic. 2014 | 34.92% | 11.39% |
31 dic. 2013 | 19.15% | 11.99% |
31 dic. 2012 | 15.43% | 11.19% |
31 dic. 2011 | 14.10% | 10.02% |
31 dic. 2010 | 15.07% | 10.09% |
31 dic. 2009 | 17.34% | 14.33% |
31 dic. 2008 | 10.41% | 10.62% |
31 dic. 2007 | 10.36% | 10.58% |
31 dic. 2006 | 12.58% | 13.20% |
31 dic. 2005 | 7.95% | 12.89% |
Basado en los informes: 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).